approval
saveSUBLOCADE (BUPRENORPHINE) — FDA approval
community read0 votes
Sponsor: INDIVIOR. Form: SOLUTION, EXTENDED RELEASE. Route: SUBCUTANEOUS
view source ↗Data sources
last refreshed 6mo ago
Found something off?
drug timeline · 8
- approvalBRIXADI (BUPRENORPHINE) — FDA approvalDec 22, 2025 · 326d ago
- approvalSUBLOCADE (BUPRENORPHINE) — FDA approvalDec 22, 2025 · 326d ago
- approvalBRIXADI (BUPRENORPHINE) — FDA approvalAug 29, 2025 · 441d ago
- approvalSUBLOCADE (BUPRENORPHINE) — FDA approvalApr 11, 2025 · 581d ago
- approvalBRIXADI (BUPRENORPHINE) — FDA approvalMar 28, 2025 · 595d ago
- approvalSUBLOCADE (BUPRENORPHINE) — FDA approvalFeb 21, 2025 · 630d ago
- approvalSUBLOCADE (BUPRENORPHINE) — FDA approvalApr 19, 2024 · 938d ago
- approvalSUBLOCADE (BUPRENORPHINE) — FDA approvalDec 15, 2023 · 1064d ago
comments(0)
5-min edit window · permanent after that